Cancer research
Recent advances in immunotherapy and nanomedicine are paving the way for transformative strategies to penetrate the blood-brain barrier in pediatric central nervous system (CNS) tumors, a major challenge that limits therapeutic delivery and contributes to poor clinical outcomes. Researchers at Imam Mohammad Ibn Saud Islamic University have developed innovative nanocarrier
Cancer research
Researchers at Weill Cornell Medicine have made a significant breakthrough in cancer immunotherapy, discovering a potent small molecule inhibitor of the lymphocyte activation gene-3 (LAG-3) protein. The novel compound, identified through a DNA-encoded chemical library (DEL) screen, exhibits submicromolar affinity for LAG-3 and disrupts the LAG-3/MHCII interaction, which plays
Cancer research
Researchers at Taiyuan University of Technology have made a significant breakthrough in the fight against cancer, developing a novel nanoparticle system that targets cancer stem cells and tumor-associated macrophages to promote immunotherapeutic efficacy. According to a study published in Colloids and Surfaces B-biointerfaces, the team successfully synthesized a mannose, polyethylene
Cancer research
Researchers from Kunming Medical University in China have published a review of the effects of anti-angiogenic therapy combined with immunotherapy and radiotherapy for the treatment of brain metastases in non-small cell lung cancer (NSCLC). The study aimed to provide ideas for the treatment of NSCLC with brain metastases. The authors
Cancer research
Researchers from the Third People's Hospital of Zhengzhou, Henan, China, have made a significant discovery in the treatment of non-small cell lung cancer (NSCLC). The study, recently published in Scientific Reports, reveals that combining neoadjuvant immunotherapy with chemotherapy can improve resection rates, survival, and progression-free survival in patients
Cancer research
A new study from Cedars-Sinai Medical Center has found that young women with breast cancer who underwent chemo-immunotherapy treatment experienced early cardiovascular toxicity, even with a low cardiovascular risk profile. Researchers retrospectively analyzed 85 women with early-stage triple-negative breast cancer who received chemotherapy and pembrolizumab between 2018 and 2023. The
Cancer research
Researchers at San Matteo Hospital Foundation have described new data in non-small cell lung cancer treatment, highlighting the potential benefits of combining immunotherapy and non-ablative radiation therapy. According to a case report published in Frontiers in Oncology, the association of immunotherapy and non-ablative radiation regimens may represent a safe and
Cancer research
Researchers from Affiliated Hospital of Qinghai University have conducted a systematic review and network meta-analysis to evaluate the efficacy and safety of combination therapies with immune checkpoint inhibitors (ICIs) in patients with non-small cell lung cancer (NSCLC) and liver metastases. The study aimed to determine the most effective first-line ICI
Cancer research
Researchers from the Department of Cardiology, Jilin Province FAW General Hospital, have made significant progress in developing nanocarrier-based delivery systems for treating bone cancer. According to a recent study published in IUBMB Life, these systems have improved the bioavailability and targeting of tyrosine kinase inhibitors (TKIs) in bone cancer therapy,
Cancer research
A team of researchers at Merck & Company in Rahway, New Jersey, has published a new study on cancer therapy, revealing key insights into the properties of vibostolimab, a humanized anti-T cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) antibody. The study, titled "Pharmacological and structural characterization of vibostolimab,
Cancer research
Current study results reveal that cancer treatments have adverse effects on female fertility, leading to a growing number of girls and women facing reproductive health challenges. Researchers from the University of Colorado have found that radiation and chemotherapy can cause permanent damage to the ovaries and uterus, resulting in a
Cancer research
Research findings on personalized medicine have shed new light on the early identification of high-risk recurrence patients in locally advanced rectal cancer. A study conducted by Koninklijke Philips N.V. - Philips Healthcare revealed that a 3D spectral CT-based fusion model can predict prognosis and postoperative adjuvant chemotherapy benefit in
